Biotoxtech Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 230

Employees

  • Stock Symbol
  • 086040

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.79
  • (As of Friday Closing)

Biotoxtech General Information

Description

Biotoxtech Co Ltd assesses safety for medical products, cosmetics, food, and chemical material. It also conducts validity tests and material screening and provides consulting services for non-clinical tests.

Contact Information

Website
www.biotoxtech.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 53 Yeongudanji-ro, Ochang-eup
  • Cheongwon-gu
  • Cheongju, Chungcheongbuk 28115
  • South Korea
+82
Primary Industry
Biotechnology
Stock Exchange
KRX
Corporate Office
  • 53 Yeongudanji-ro, Ochang-eup
  • Cheongwon-gu
  • Cheongju, Chungcheongbuk 28115
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotoxtech Stock Performance

As of 13-Nov-2026, Biotoxtech’s stock price is $1.79. Its current market cap is $27.6M with 15.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.79 $1.75 $1.23 - $2.85 $27.6M 15.4M 12K -$0.18

Biotoxtech Financials Summary

As of 30-Jun-2026, Biotoxtech has a trailing 12-month revenue of $36.2M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 39,317 51,741 53,032 98,200
Revenue 36,159 33,037 30,299 24,958
EBITDA 2,329 5,979 (659) (4,146)
Net Income (2,753) 817 (4,711) (3,731)
Total Assets 85,776 91,393 92,460 114,098
Total Debt 44,302 43,402 42,804 47,794
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biotoxtech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biotoxtech‘s full profile, request access.

Request a free trial

Biotoxtech Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • Pending

  • Expiring in next 12 mo

Biotoxtech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021029656-A1 Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis, containing hydroquinone derivative and obeticholic acid Inactive 14-Aug-2019
JP-2022509467-A A pharmaceutical composition for the prevention or treatment of obesity or non-alcoholic steatohepatitis containing a hydroquinone derivative. Active 25-Oct-2018
US-12102612-B2 Pharmaceutical composition comprising hydroquinone derivative for preventing or treating obesity or nonalcoholic steatohepatitis Active 25-Oct-2018
US-20210393566-A1 Pharmaceutical composition comprising hydroquinone derivative for preventing or treating obesity or nonalcoholic steatohepatitis Active 25-Oct-2018
WO-2020085644-A1 Pharmaceutical composition comprising hydroquinone derivative for preventing or treating obesity or nonalcoholic steatohepatitis Inactive 25-Oct-2018 A61K31/122
To view Biotoxtech’s complete patent history, request access »

Biotoxtech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotoxtech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biotoxtech‘s full profile, request access.

Request a free trial

Biotoxtech Investments (3)

Biotoxtech’s most recent deal was a Joint Venture with ABC Bioscience. The deal was made on 01-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ABC Bioscience 01-Oct-2023 Joint Venture Consulting Services (B2B)
Biomix (Biotechnology) 16-Oct-2017 Corporate Biotechnology
SCAS-BTT Bioanalysis 02-May-2011 Joint Venture Other Pharmaceuticals and Biotechnology
To view Biotoxtech’s complete investments history, request access »

Ready to get started?

Request a free trial

Biotoxtech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Services

Subindustry

Rank

Percentile

To view Biotoxtech’s complete esg history, request access »

Biotoxtech FAQs

  • When was Biotoxtech founded?

    Biotoxtech was founded in 2000.

  • Where is Biotoxtech headquartered?

    Biotoxtech is headquartered in Cheongju, South Korea.

  • What is the size of Biotoxtech?

    Biotoxtech has 230 total employees.

  • What industry is Biotoxtech in?

    Biotoxtech’s primary industry is Biotechnology.

  • Is Biotoxtech a private or public company?

    Biotoxtech is a Public company.

  • What is Biotoxtech’s stock symbol?

    The ticker symbol for Biotoxtech is 086040.

  • What is the current stock price of Biotoxtech?

    As of 13-Nov-2026 the stock price of Biotoxtech is $1.79.

  • What is the current market cap of Biotoxtech?

    The current market capitalization of Biotoxtech is $27.6M.

  • What is Biotoxtech’s current revenue?

    The trailing twelve month revenue for Biotoxtech is $36.2M.

  • What is Biotoxtech’s annual earnings per share (EPS)?

    Biotoxtech’s EPS for 12 months was -$0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process